InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:

NOVOGEN LIMITED (NRT)
(This company subsequently changed its name to KAZIA THERAPEUTICS LIMITED. You should refer to that name for Status.)

Date of Listing:

01 September 1994

Subsequent Names:

Company Name	Start Date	End Date
KAZIA THERAPEUTICS LIMITED	29/11/2017

Former Names:

Stock Exchange Status: (updated daily)

This company subsequently changed its name to KAZIA THERAPEUTICS LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

This company subsequently changed its name to KAZIA THERAPEUTICS LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now KAZIA THERAPEUTICS LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

NOVOGEN LIMITED(NRT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
NOVOGEN LIMITED	13/05/1997	29/11/2017
NORVET LIMITED		13/05/1997

Shareholder links

Our website ranking of NRT:

(4 out of 5)

COMPANY WEBSITE:

NRT website

NRT email

NRT investorRelations

NRT annualreports

REGISTRY:

6 Hope St Ermington NSW 2115

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Level 5, 20 George St, Hornsby, NSW, 2077
Tel: + 61 2 9476 0344 Fax: + 61 2 9476 0388

Date first listed: 01/09/1994
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on phenolic technology

News & Events

Expand this box to read and print

name changed to Kazia Therapeutics Limited	29/11/2017
we understand that on or about this date the company consolidated its shares 1 for 10	24/11/2017
The suspension of trading in the securities of Novogen Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the completion of a capital raising. Security Code: NRT	12/11/2014
the Closing Date of its current capital raising using the ASX BookBuild Facility has been extended from today Friday 7 November 2014 at 3 pm, to next Tuesday 11 November 2014	07/11/2014
has received confirmation that its experimental drug product, Cantrixil, has passed its final pre-clinical test of efficacy as evidence of its potential to significantly improve the survival prospects of patients with late-stage ovarian cancer	06/11/2014
The securities of Novogen Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a placement. Security Code: NRT	05/11/2014
we understand that on or about this date the company made an in specie distribution of 3 shares in MEI Pharma, Inc for every 40 shares in the company	27/11/2012
name changed from Norvet Limited	13/05/1997

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
27/06/2017	Bryce Carmine	600,000	$0.049	$29,400.00
14/06/2017	Iain Ross	1,000,000	$0.055	$55,005.00
13/06/2017	Steven Coffey	320,000	$0.057	$18,240.00
13/06/2017	James Garner	125,000	$0.057	$7,125.00
24/02/2017	Steven Coffey	100,000	$0.086	$8,550.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Iain Ross	Non Exec Chairman	22/07/2015
Mark Hinze	CFO	18/06/2010
Steven Coffey	Non Exec Director	08/11/2012
Bryce Carmine	Non Exec Director	03/06/2015
James Garner	Executive Director, CEO	01/02/2016
Kate Hill	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.